Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Randomized Study to Evaluate the Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Receiving Moderately Emetogenic Chemotherapy in France.

NCT03831633 is registered in ClinicalTrials.gov with VIFORFRANCE as lead sponsor.

NCT NCT03831633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Randomized Study to Evaluate the Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Receiving Moderately Emetogenic Chemotherapy in France.
Lead sponsor
VIFORFRANCE
Phase
Phase 4
Overall status
Unknown status
Start date
September 19, 2018
Completion date
July 31, 2019
Enrollment
426 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oncology